Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jetske van der Schaar"'
Autor:
Lisa Waterink, Larissa A. Masselink, Sven J. van der Lee, Leonie N. C. Visser, Solange Cleutjens, Jetske van der Schaar, Argonde C. van Harten, Philip Scheltens, Sietske A. M. Sikkes, Wiesje M. van der Flier, Marissa D. Zwan
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background Apolipoprotein-E (APOE) genetic testing for Alzheimer’s disease is becoming more important as clinical trials are increasingly targeting individuals carrying APOE-ε4 alleles. Little is known about the interest in finding out on
Externí odkaz:
https://doaj.org/article/42b3b0c2cdb74855a9ee7e49bcdf3ba0
Autor:
Jetske van der Schaar, Leonie N. C. Visser, Femke H. Bouwman, Johannes C. F. Ket, Philip Scheltens, Annelien L. Bredenoord, Wiesje M. van der Flier
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-12 (2022)
Abstract Background The NIA-AA research framework proposes a purely biological definition of Alzheimer’s disease (AD). This implies that AD can be diagnosed based on biomarker abnormalities, irrespective of clinical manifestation. While this brings
Externí odkaz:
https://doaj.org/article/c895b6735a8c41b0836d93a8bc9e8e0e
Autor:
Leonie N. C. Visser, Carolina Minguillon, Gonzalo Sánchez-Benavides, Marc Abramowicz, Daniele Altomare, Karine Fauria, Giovanni B. Frisoni, Jean Georges, Federica Ribaldi, Philip Scheltens, Jetske van der Schaar, Marissa Zwan, Wiesje M. van der Flier, José Luis Molinuevo
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-12 (2021)
Abstract Growing evidence suggests dementia incidence can be reduced through prevention programs targeting risk factors. To accelerate the implementation of such prevention programs, a new generation of brain health services (BHS) is envisioned, invo
Externí odkaz:
https://doaj.org/article/3a8456a54c3e491592d3cd0e2a363097
Autor:
Jetske van der Schaar, Leonie N. C. Visser, Femke H. Bouwman, Johannes C. F. Ket, Philip Scheltens, Annelien L. Bredenoord, Wiesje M. van der Flier
Publikováno v:
van der Schaar, J, Visser, L N C, Bouwman, F H, Ket, J C F, Scheltens, P, Bredenoord, A L & van der Flier, W M 2022, ' Considerations regarding a diagnosis of Alzheimer’s disease before dementia : a systematic review ', Alzheimer's Research and Therapy, vol. 14, no. 1, 31 . https://doi.org/10.1186/s13195-022-00971-3
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-12 (2022)
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-12 (2022)
Background The NIA-AA research framework proposes a purely biological definition of Alzheimer’s disease (AD). This implies that AD can be diagnosed based on biomarker abnormalities, irrespective of clinical manifestation. While this brings opportun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e5cc76e1bec41afd22b9dcba1ed22f
https://research.vumc.nl/en/publications/7b45c7e8-b0b5-4570-b02d-2123a1d928ac
https://research.vumc.nl/en/publications/7b45c7e8-b0b5-4570-b02d-2123a1d928ac
Autor:
Agnetha D. Fruijtier, Jetske van der Schaar, Ingrid S. van Maurik, Marissa D. Zwan, Philip Scheltens, Femke Bouwman, Yolande A.L. Pijnenburg, Bart N.M. van Berckel, Jarith Ebenau, Wiesje M. van der Flier, Ellen M.A. Smets, Leonie N.C. Visser
Publikováno v:
Alzheimer s & dementia. Elsevier Inc.
Alzheimer's and Dementia. Elsevier
Fruijtier, A D, van der Schaar, J, van Maurik, I S, Zwan, M D, Scheltens, P, Bouwman, F, Pijnenburg, Y A L, van Berckel, B N M, Ebenau, J, van der Flier, W M, Smets, E M A & Visser, L N C 2022, ' Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial ', Alzheimer's and Dementia . https://doi.org/10.1002/alz.12630, https://doi.org/10.1002/alz.12630
Alzheimers & Dementia. Elsevier
Alzheimer's and Dementia. Elsevier
Fruijtier, A D, van der Schaar, J, van Maurik, I S, Zwan, M D, Scheltens, P, Bouwman, F, Pijnenburg, Y A L, van Berckel, B N M, Ebenau, J, van der Flier, W M, Smets, E M A & Visser, L N C 2022, ' Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial ', Alzheimer's and Dementia . https://doi.org/10.1002/alz.12630, https://doi.org/10.1002/alz.12630
Alzheimers & Dementia. Elsevier
Introduction: Empirical studies on effective communication for amyloid disclosure in mild cognitive impairment (MCI) are lacking. We aimed to study the impact of six communication strategies. Method: We performed a randomized controlled trial with se
Autor:
Wiesje M. van der Flier, Marissa D. Zwan, Philip Scheltens, Larissa A Masselink, Sven J. van der Lee, Leonie Nc Visser, Solange Cleutjens, Jetske van der Schaar
Publikováno v:
Alzheimer's & Dementia. 16